Aisling Capital portfolio
40 tracked investments, 3 on the map, $2.7B raised across the mapped portfolio.
Aisling Capital40 investments · 3 on the map · $2.7B raised- ESPERION THERAPEUTICSVenture
- Compass Pathways
- Scholar RockPost-IPO Equity
Also in the portfolio
- Forge Biologics
- Biomea Fusion
- Treeline Biosciences
- BridgeBio
- Dren Bio
- GondolaBio
- Ajax Health
- Ascendis Pharma
- CalciMedica
- Promentis Pharmaceuticals
- VIVUS
- Poseida Therapeutics
- Pharmaron
- Atreca
- Chimerix
- ObsEva
- Dermira
- Aeglea BioTherapeutics
- Aimmune Therapeutics
- Eidos Therapeutics
- Infinity Pharmaceuticals
- Nabriva Therapeutics
- Intersect ENT
- Zosano Pharma
- GTx
- LENSAR
- Roka Bioscience
- Miramar Labs
- Sirion Therapeutics
- Cempra
- Aton Pharma
- Xanodyne
- PreCision Dermatology
- Axcan Pharmaceuticals
- Zeltiq Aesthetics
- FBG Limited
- Bridge Pharmaceuticals
Investors similar to Aisling Capital
Polaris Partners148 investments · 99 on the map · $1.9B raised
RA Capital Management150 investments · 92 on the map · $6.7B raised
Invus86 investments · 16 on the map · $3.7B raised
Redmile Group61 investments · 14 on the map · $5.4B raised
Oxford Finance LLC51 investments · 11 on the map · $1.7B raised
TCG Crossover27 investments · 9 on the map · $4.1B raised